Tarsus Pharmaceuticals TARS
NASDAQ TARS
$77.16 +0.40 (+0.52%)
As of: Nov 12, 2026 · 12:53 PM EST

Tarsus Pharmaceuticals (TARS) Interest & Investment Income (2021 - 2026)

Updated

Tarsus Pharmaceuticals (TARS) posted Interest & Investment Income of $3.78 million for Q3 2026, down 8.2% from $4.11 million a year earlier but up 2.1% from the prior quarter.

Analysis

Tarsus Pharmaceuticals (TARS) Interest & Investment Income (2021 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Interest & Investment Income at Tarsus Pharmaceuticals was $15.15 million, down 1.9% year-over-year; for FY2025, it came in at $15.75 million, up 4.9% from FY2024.

  • Annual Interest & Investment Income has increased for three consecutive years, with a three-year compound annual growth rate of 65.1% (FY2022 to FY2025).
  • In prior years, Tarsus Pharmaceuticals' Interest & Investment Income was $15.01 million in FY2024 (+45.2%), $10.34 million in FY2023 (+195.4%) and $3.5 million in FY2022.
  • Quarterly Interest & Investment Income has run from a low of $297,000 in Q2 2022 to a high of $4.23 million in Q2 2025 over five years.
  • On a year-over-year basis, Interest & Investment Income increased in five of the last eight quarters, with growth averaging 3.9%.
  • The strongest year-over-year quarter for Interest & Investment Income in the past five years was Q2 2023, with growth of 649.5%; the weakest was Q2 2026, with a decline of 12.6%.
  • According to Business Quant data, Interest & Investment Income for the three prior quarters was $3.7 million (Q2 2026), $3.72 million (Q1 2026) and $3.95 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 186.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 67.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Tarsus Pharmaceuticals 3.64 Bn 2.07 Bn 180.68 Mn 3.78 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 3.78 Mn
Jun 30, 2026 3.70 Mn
Mar 31, 2026 3.72 Mn
Dec 31, 2025 3.95 Mn
Sep 30, 2025 4.11 Mn
Jun 30, 2025 4.23 Mn
Mar 31, 2025 3.45 Mn
Dec 31, 2024 3.65 Mn
Sep 30, 2024 4.12 Mn
Jun 30, 2024 4.13 Mn
Mar 31, 2024 3.12 Mn
Dec 31, 2023 2.98 Mn
Sep 30, 2023 2.84 Mn
Jun 30, 2023 2.23 Mn
Mar 31, 2023 2.29 Mn
Dec 31, 2022 2.13 Mn
Sep 30, 2022 1.06 Mn
Jun 30, 2022 297,000.00
Dec 31, 2021 12,000.00
Sep 30, 2021 8,000.00
API Access

Tarsus Pharmaceuticals Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=TARS&period=max&api_key=YOUR_API_KEY